Figure 1.

Scatter plot of trials comparing celecoxib with NSAID for discontinuations due to gastrointestinal adverse events. Celecoxib at any dose is represented. The red symbol represents the longest trial, at 52 weeks. GI, gastrointestinal; NSAID, nonsteroidal anti-inflammatory drug.

Moore et al. Arthritis Research & Therapy 2005 7:R644-R665   doi:10.1186/ar1704
Download authors' original image